Earnings Per Share (Tables)

6 Months Ended

Jun. 30, 2022

Schedule of Earnings Per Share, Basic and Diluted

A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021
Numerator:
Net loss attributable to Surgery Partners, Inc.	$	(18.4)	$	(26.9)	$	(6.2)	$	(47.9)
Less: amounts allocated to participating securities (1)	—		—		—		(10.3)
Net loss attributable to common stockholders	$	(18.4)	$	(26.9)	$	(6.2)	$	(58.2)

Denominator:
Weighted average shares outstanding- basic	88,900		69,267		88,450		62,060
Weighted average shares outstanding- diluted (2)	88,900		69,267		88,450		62,060

Loss per share:
Basic	$	(0.21)	$	(0.39)	$	(0.07)	$	(0.94)
Diluted (2)	$	(0.21)	$	(0.39)	$	(0.07)	$	(0.94)

Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:
Stock options	1,559		2,016		1,599		1,901
Restricted shares	628		1,484		644		1,451

(1)Includes dividends accrued for the Series A Preferred Stock for the six months ended June 30, 2021. The Series A Preferred Stock did not participate in undistributed losses and was converted to common stock during the second quarter of 2021. There were no participating securities for the three and six months ended June 30, 2022 and the three months ended June 30, 2021.

(2)The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive.